Pharmaceutical Industry: From Molecule to Medicine | Updated

Name: Pharmaceutical Industry: From Molecule to Medicine | Updated
Rating: 5.0 (72 reviews)

Pharma 360°: Understanding of Drug Development, Regulation, and Healthcare Markets, From Drug Discovery to Patient Care.

Created byArbab Majeed

Last updated 6/2026

English

English [Auto],

What you'll learn

Understand the structure and key components of the global pharmaceutical industry and how different sectors work together.
Learn the differences between innovator and generic pharmaceutical companies and their roles in medicine development.
Identify the responsibilities of major healthcare stakeholders, including patients, providers, payers, and regulatory organizations.
Explore the history and major milestones that shaped modern medicine and pharmaceutical innovation.
Understand the economics of healthcare systems and the factors influencing pharmaceutical spending.
Learn the complete drug discovery process, including target identification, validation, screening, lead optimization, and preclinical evaluation.
Gain knowledge of Investigational New Drug (IND) requirements and the transition from laboratory research to human studies.
Learn about clinical trial ethics, Institutional Review Boards (IRBs), data management, and the role of biostatistics.
Learn the importance of Good Manufacturing Practices (GMP), Quality Assurance (QA), Quality Control (QC), and compliance systems.
Understand Chemistry, Manufacturing, and Controls (CMC) documentation and its role in regulatory approval.
Understand pharmaceutical supply chains, cold chain logistics, and medicine distribution processes.
Understand pharmacovigilance systems, adverse event reporting, and ongoing medicine safety monitoring.
Develop a complete understanding of how a drug progresses from initial discovery to global patient access.
Build foundational knowledge for careers in pharmaceutical research, clinical development, regulatory affairs, quality management, healthcare, and related field

Course content

5 sections • 25 lectures • 1h 39m total length

Defining the Global Pharmaceutical Landscape4:09
Core Sectors: Innovator vs. Generic Pharmaceutical Companies3:53
Examine how innovator companies invest billions to discover new molecules, file patents, and run trials to secure market exclusivity, then contrast with generics lowering costs after patent cliffs.
Key Stakeholders: Patients, Providers, Payers, and Regulators3:55
Explore how patients, providers, payers, and regulators shape pharmaceutical outcomes, from patient-centered care and advocacy to evidence-based decisions, formulary economics, and rigorous regulatory oversight.
Historical Milestones in Modern Medicine4:08
Economics of Healthcare and Pharmaceutical Spending3:54
Explore how macroeconomics shapes global healthcare spending, including pharmaceutical costs, value-based pricing, and health technology assessment, using cost per quality-adjusted life year to guide budgets and access.

Target Identification and Validation Processes4:13
Identify molecular targets—proteins, genes, or receptors—using genomic sequencing and high-throughput proteomics to map disease biology. Validate targets with gene knockout or RNA interference to prove therapeutic benefit; engage multidisciplinary teams.
High-Throughput Screening and Lead Optimization3:54
Identify hits through high-throughput screening and refine them into lead compounds via iterative synthesis, testing, and data analysis to optimize potency, selectivity, and drug-like properties toward a development candidate.
Preclinical Testing: In-Vitro and In-Vivo Models4:15
Pharmacokinetics and Pharmacodynamics (PK/PD) Principles3:54
Master the pharmacokinetics and pharmacodynamics framework to understand absorption, distribution, metabolism, and excretion, and apply dose-response concepts to design safe, effective dosing regimens that optimize patient safety.
Investigational New Drug (IND) Application Requirements4:00

Phase I Clinical Trials: Safety and Dosage Parameters3:39
Phase I clinical trials assess safety and identify the maximum tolerated dose via dose escalation in healthy volunteers, while collecting pharmacokinetics data to inform future dosing.
Phase II Clinical Trials: Efficacy and Side Effect Profiling3:53
Phase II trials test a drug's efficacy in patients and map a comprehensive side-effect profile. They use dose-ranging studies to identify the optimal therapeutic dose before advancing to Phase III.
Phase III Clinical Trials: Large-Scale Effectiveness Tracking3:56
Phase III trials test definitive efficacy and safety at large scale across diverse populations, using randomized, controlled, double-blind designs to prove superior or non-inferior outcomes for regulatory approval.
Ethical Guidelines and Institutional Review Boards (IRB)3:49
Ensure ethical guidelines such as the Declaration of Helsinki and the Belmont Report guide clinical trials, with IRB oversight protecting participants' welfare, rights, respect, safety, and informed consent.
Clinical Trial Data Management and Biostatistics Basics3:54
Learn how clinical trial data management converts patient charts and results into a secure, traceable database, then apply biostatistics and a predefined analysis plan to assess treatment effects and p-values.

Role of Global Regulatory Agencies (FDA, EMA, PMDA)3:58
New Drug Application (NDA) and Biologics License Application (BLA)3:51
Discover how NDA and BLA submissions use the common technical document, organized into five modules: administration; summaries; chemistry, manufacturing and controls; nonclinical data; and clinical trial reports.
Good Manufacturing Practices (GMP) and Facility Compliance4:05
Maintain patient safety by enforcing GMP across all operations, from validated equipment and clean rooms to cross-contamination controls, traceable batch records, and unannounced regulatory inspections.
Quality Assurance (QA) vs. Quality Control (QC) Frameworks3:55
Chemistry, Manufacturing, and Controls (CMC) Documentation3:59
Dive into chemistry, manufacturing, and controls (CMC) documentation driving regulatory submissions, detailing active pharmaceutical ingredients, finished drug products, stability, and post-approval variations.

Pricing Strategies and Health Economics Outcomes Research (HEOR)3:57
Market Access and Formulary Placement Mechanics4:01
Explore how market access hinges on formulary placement, pharmacy and therapeutics oversight, cost-effectiveness, and utilization controls like prior authorization and step therapy to ensure patient access.
Pharmaceutical Supply Chain and Cold Chain Logistics4:17
Map the pharmaceutical distribution network from factory to patient, highlighting strict regulation, pedigree verification, and cold-chain logistics that safeguard biologics with real-time temperature, humidity, and location monitoring.
Phase IV Trials and Real-World Evidence (RWE)4:06
Track Phase IV post-marketing surveillance and real-world evidence to monitor safety, efficacy, rare adverse events, and opportunities for indication expansion across diverse populations.
Pharmacovigilance and Adverse Event Reporting Systems4:00

Requirements

No prior experience in the pharmaceutical industry is required.
A willingness to learn scientific concepts, research processes, and healthcare systems is essential.

Description

This course contains the use of Artificial Intelligence.

It's an Unofficial Course.

The Pharmaceutical Industry Masterclass is a comprehensive course designed to provide a complete understanding of the global pharmaceutical ecosystem, covering every stage of the medicine development journey from scientific discovery to patient access. This course explores how pharmaceutical companies operate, how innovative medicines are created, tested, regulated, manufactured, and brought to healthcare markets worldwide.

Throughout this course, you will gain a strong foundation in the structure of the pharmaceutical industry, including the roles of innovator and generic pharmaceutical companies, healthcare stakeholders, regulatory authorities, and the economic factors influencing pharmaceutical development and spending. You will explore the history of modern medicine and understand how scientific breakthroughs have transformed healthcare over time.

The course takes you deep into the drug discovery and development process, explaining how potential drug targets are identified, validated, and optimized through advanced research methods. You will learn about preclinical studies, laboratory models, pharmacokinetics, pharmacodynamics, and the essential requirements for advancing a drug candidate toward human testing.

You will also develop a detailed understanding of clinical trial methodology, including the purpose and structure of Phase I, Phase II, and Phase III trials. The course covers clinical trial design, safety evaluation, efficacy assessment, ethical principles, Institutional Review Boards, data management, and the role of biostatistics in generating reliable scientific evidence.

A major focus of this course is pharmaceutical regulation and quality systems. You will learn how global regulatory agencies evaluate medicines, how drug approval applications are prepared, and why compliance with Good Manufacturing Practices (GMP), Quality Assurance (QA), Quality Control (QC), and Chemistry, Manufacturing, and Controls (CMC) requirements is essential for ensuring safe and effective medicines.

Beyond research and approval, this course examines the commercial side of pharmaceuticals, including pricing strategies, health economics, market access, formulary decisions, supply chain operations, cold chain logistics, and the importance of real-world evidence. You will also explore post-market safety monitoring, pharmacovigilance systems, adverse event reporting, and the continuous evaluation of medicines after they reach patients.

By the end of this course, you will have a complete end-to-end understanding of the pharmaceutical lifecycle and the interconnected processes that transform scientific ideas into approved healthcare solutions.

Whether you are interested in pharmaceutical research, clinical development, regulatory affairs, quality management, healthcare business, or simply want to understand how modern medicines reach patients, this course provides valuable knowledge and practical industry insight.

Thank you

Who this course is for:

Students and graduates in pharmacy, medicine, life sciences, biotechnology, healthcare, and related fields who want to understand the pharmaceutical industry.
Pharmacy students and professionals seeking a broader understanding of drug development, clinical research, and regulatory processes.
Healthcare professionals who want to learn how medicines move from discovery to patient care.
Individuals interested in pharmaceutical research, clinical trials, regulatory affairs, quality assurance, and drug commercialization.
Medical and life science graduates looking to build foundational knowledge for careers in the pharmaceutical sector.
Researchers and scientists who want to understand the complete pharmaceutical development pathway beyond laboratory research.
Business, management, and healthcare professionals interested in pharmaceutical markets, pricing, market access, and industry operations.
Professionals transitioning into pharmaceutical, biotechnology, or healthcare-related careers.
Entrepreneurs, investors, and industry enthusiasts who want to understand how the global pharmaceutical ecosystem works.
Anyone interested in learning how modern medicines are discovered, tested, approved, manufactured, and monitored for safety.

Pharmaceutical Industry: From Molecule to Medicine | Updated

What you'll learn

Explore related topics

Course content

Introduction to the Pharmaceutical Ecosystem5 lectures • 20min

The Drug Discovery Framework5 lectures • 20min

Clinical Trials Methodology5 lectures • 19min

Regulatory Affairs and Quality Assurance5 lectures • 20min

Commercialization and Post-Market Monitoring5 lectures • 20min

Requirements

Description

Who this course is for: